
Sign up to save your podcasts
Or


Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.
By Chemistry World4.7
183183 ratings
Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.

3,196 Listeners

544 Listeners

818 Listeners

2,367 Listeners

328 Listeners

6,592 Listeners

3,358 Listeners

384 Listeners

151 Listeners